Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (24)

2024

  1. Effectiveness and safety of XEN63 in patients with primary-open-angle glaucoma

    Scientific Reports, Vol. 14, Núm. 1

  2. XEN® 45 en el manejo quirúrgico del glaucoma en fases tempranas: estudio nacional de consenso según metodología Delphi

    Archivos de la Sociedad Española de Oftalmologia, Vol. 99, Núm. 3, pp. 98-108

2023

  1. Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients

    Seminars in Arthritis and Rheumatism, Vol. 58

  2. Correction to: Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis (Ophthalmology and Therapy, (2023), 12, 2, (1045-1055), 10.1007/s40123-023-00654-8)

    Ophthalmology and Therapy

  3. Impacto presupuestario de XEN®63 en el tratamiento del glaucoma primario de ángulo abierto en España

    Archivos de la Sociedad Española de Oftalmologia, Vol. 98, Núm. 1, pp. 2-10

  4. Progresión en glaucoma. Guía de práctica clínica

    Archivos de la Sociedad Española de Oftalmologia, Vol. 98, Núm. 1, pp. 40-57

  5. Spontaneous resolution of inflammatory epiretinal membrane: Case series and review of the literature

    European Journal of Ophthalmology, Vol. 33, Núm. 1, pp. NP10-NP14

  6. Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis

    Ophthalmology and Therapy, Vol. 12, Núm. 2, pp. 1045-1055

2020

  1. Comparing in-vivo confocal microscopy and ex-vivo light and scanning electron microscopy images of the hairs of the pine processionary caterpillar embedded in the cornea: Report of three cases

    Indian Journal of Ophthalmology, Vol. 68, Núm. 8, pp. 1672-1675

  2. Systemic Regulatory T Cells and IL-6 as Prognostic Factors for Anatomical Improvement of Uveitic Macular Edema

    Frontiers in Immunology, Vol. 11

2019

  1. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

    American Journal of Ophthalmology, Vol. 200, pp. 85-94

  2. Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

    Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089

  3. Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis

    PLoS ONE, Vol. 14, Núm. 1

2018

  1. Behavior of hyperreflective foci in non-infectious uveitic macular edema, a 12-month follow-up prospective study

    BMC Ophthalmology

  2. Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review

    Clinical and experimental rheumatology, Vol. 36, Núm. 4, pp. 652-657

  3. Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease

    Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451

2017

  1. Development of an activity disease score in patients with uveitis (UVEDAI)

    Rheumatology International, Vol. 37, Núm. 4, pp. 647-656

2016

  1. Carga y costes directos de la uveítis no infecciosa en España

    Reumatologia Clinica, Vol. 12, Núm. 4, pp. 196-200

  2. Clinical Manifestations and Outcomes of Syphilis-associated Uveitis in Northern Spain

    Ocular Immunology and Inflammation, Vol. 24, Núm. 2, pp. 147-152

2015

  1. Specific association of IL17A genetic variants with panuveitis

    British Journal of Ophthalmology, Vol. 99, Núm. 4, pp. 566-570